Pac Roots Completes Acquisition of Cannabis Act License Applicant and Related Phenome One Genetic Licensing Transaction
Pac Roots Cannabis Corp. (formerly Mountain Lake Minerals Inc.) (CSE:MLK) (the “Company”) is pleased to announce that, further to its press releases dated March 15, 2018, June 8, 2018, July 12, 2018, July 18, 2018, January 18, 2019, April 5, 2019, April 11, 2019, June 7, 2019, August 15, 2019, the Company has completed its previously announced acquisition of an application for a license under the Cannabis Act (Canada), indirectly through the acquisition of 1157630 B.C. Ltd.. (the “Acquisition”) as well as the licensing arrangement with Phenome One Corp. (“Phenome”), a private held full service live genetic cannabis company. The Company has also changed its name from Mountain Lake Minerals Inc. to “Pac Roots Cannabis Corp.”. The Company expects to commence trading on the Canadian Securities Exchange (“CSE”) on May 4, 2020 under the symbol “PACR”. (CSE:PACR)
As previously announced, under the provisions of the Acquisition, the Company acquired all of the issued and outstanding securities of 1157630 B.C. Ltd. (the “Target”) in consideration of the issuance of 40,000,000 common shares of the Company (the “Payment Shares”). The Target is now a wholly owned subsidiary of the Company. All of the Payment Shares are subject to escrow pursuant to the policies of the CSE and will be released from escrow based on the passage of time, such that 10% of the securities were released on closing and the balance will be released in six equal tranches of 15% every six months thereafter. An additional, 3,383,333 common shares were issued to a historical owner of the Target’s wholly owned subsidiary, Go Green Medicinal Marijuana Ltd. (“Go Green”), which common shares are subject to resale restrictions expiring on August 29, 2020.
Go Green holds an application for a license under the Cannabis Act (Canada) which has successfully advanced through the review and security clearance stages of the license application process and expects to complete the pre-licensing and approval process following the submission of its security and video evidence package in Q2 2020, following which Go Green expects it would be issued its license. Go Green has a 12,000 square foot indoor growing facility in Lake Country, British Columbia. Go Green has nearly completed an expansion on the facility which will increase its size to 22,000 square feet.
Upon the completion of the closing of the Acquisition, the Company issued 200,000 common shares to Matthew McGill pursuant to a finder’s fee agreement dated June 6, 2018 (the “Finder’s Fee Agreement”) entered into in association with the Acquisition. These shares are subject to a hold period under securities laws ending on August 29, 2020 and are also held in escrow on the same terms as the Payment Shares. Mr. McGill is a director of the Company and thus a related party to the Company. At the time the Finder’s Fee Agreement was executed however, Mr. McGill was not associated with the Issuer and as a result the Finder’s Fee Agreement and the issuance of the common shares thereunder does not constitute a ‘related party transaction’ pursuant to Multilateral Instrument 61-101 – Protection of Minority Securityholders in Special Transactions.
Phenome One License
The Company has entered into a genetic licensing royalty agreement dated April 8, 2019, as amended (the “Licensing Agreement”) with Phenome. The Licensing Agreement provides the Company with full access to Phenome’s entire library of cultivars as well as access to Phenome’s farming intellectual property (“IP”). The Company will also be granted unlimited access to Norstar Nutrients’ (“Norstar”) proprietary nutrient IP and catalogue.
In consideration for the rights granted to the Company under the Licensing Agreement, the Company will pay an aggregate of $250,000 in cash and issue an aggregate of 10,000,000 common shares in the capital of the Company to Phenome over a 30-month period, of which 2,500,000 common shares were issued upon closing.
The Company will also make non-refundable, non-creditable royalty payments to Phenome equal to five percent (5%) of gross sales of products. The Company will acquire a 50% interest in all hybrid cultivars generated from the extensive selective breeding program at the Lake Country facility.
In connection with the closing of Acquisition and License, the Company completed a non-brokered private placement (the “Placement”) generating aggregate gross proceeds of $1,650,000 through the issuance of 5,500,004 units at a price of $0.30 per unit (each a “Unit”).
Each Unit comprised one common share of the Company and one share purchase warrant entitling the holder to acquire one additional common shares of the Company at an exercise price of $0.50 per share until April 28, 2022.
Finder’s fees of $63,906.49 were paid to registrants along with the issuance of 213,022 finder’s warrants on the same terms as the warrants forming part of the Units.
All of the securities issued in the Placement are subject to resale restrictions expiring on August 29, 2020.
Two directors of the Company participated directly and indirectly in the Placement acquiring an aggregate of 378,850 Units on the same basis as other subscribers. The participation in the placement by insiders of the Company constitutes a “related party transaction” as such term is defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The Company is relying on exemptions from the formal valuation and minority approval requirements under MI 61-101. The Company relied on Section 5.5(a) of MI 61-101 for an exemption from the formal valuation requirement and Section 5.7(1)(a) of MI 61-101 for an exemption from the minority shareholder approval requirement of MI 61-101 as the fair market value of the Placement in so far as the Placement involved interested parties did not exceed 25% of the Company’s market capitalization.
Following completion of the Acquisition, the Company now has 63,832,966 issued and outstanding common shares.
The Company also advises that it has extended the terms of 6,914,333 currently existing warrants exercisable at $0.50 per share expiring on dates ranging from March 29, 2020 to August 16, 2020 to April 28, 2021.
Following the completion of the Placement, the Company has an aggregate of 12,627,355 warrants outstanding all exercisable at a price of $0.50 per share.
Changes to Board and Management
Following the completion of the Acquisition, Paul Smith resigned as President, Chief Executive Officer and Chief Financial Officer of the Company and as director.
Patrick Elliott, a founder of the Target has been appointed as the Company’s President and CEO and a director and William Fleming has been appointed as the Company’s Chief Financial Officer and Corporate Secretary.
The Company’s board of directors now comprises, Patrick Elliott, Marc Geen, Matthew McGill and William Fleming.
Update on Proposed Spin-Off of Mining Assets
Pursuant to the arrangement agreement dated June 5, 2018 (the “Arrangement Agreement”) between the Company and its wholly owned subsidiary, 1167343 B.C. Ltd. (“Newco”), the Company will complete a plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”) which will result in the transfer of its interests in existing mineral properties along with $1,000,000 in cash, less advances previously made by the Company to Newco of $450,000, in exchange for the issuance of common shares of Newco on the basis of one common shares of Newco for each common share of the Company held. Newco also currently holds the Highfield property, located in Nova Scotia. The Arrangement was approved by the Company’s shareholders on August 8, 2019 and received the final approval of the British Columbia Supreme Court on August 12, 2019.
The Company has determined to fix April 28, 2020 as the record date (the “Record Date”) for the proposed distribution of Newco shares. The Company will provide a further update on the proposed effective date of the Arrangement and distribution of the Newco shares in a subsequent press release.
Details of the Acquisition and the License are contained in the Company’s listing statement dated April 28, 2020 which will be filed on the Company’s profile on www.sedar.com and the website of the CSE at www.thecse.com.
Filing of Q4 2019 Financial Statements; Extension for Q1 2020
Further to the Company’s press release dated March 30, 2020, the Company is pleased to advise it has now filed its audited annual financial statements and associated management’s discussion and analysis (“MD&A”) for the year ended November 30, 2019.
The Company has however delayed the release of its interim financial statements and associated MD&A for the three months ended February 29, 2020. The Company will be relying on the 45-day filing and delivery extension for periodic filings required to be made on or before June 1, 2020 as provided by the British Columbia, Alberta and Alberta Ontario Commissions in their recent blanket orders in respect of:
- the requirement to file interim financial statements for the three-month period ended February 29, 2020 (the “Interim Financial Statements”) within 60 days of the Company’s first quarter as required by section 4.4(b) of National Instrument 51-102 (“NI 51-102”);
- the requirement to file MD& for the period covered by the Interim Financial Statements within 60 days of the Company’s first quarter as required by section 5.1(2) of NI 51-102;
- the requirement to file certifications of the Interim Financial Statements (the “Interim Certificates” and collectively with the Interim Financial Statements and MD&A, the “Interim Filings”) pursuant to section 5.1 of NI 52-109;
The Company expects that the Interim Filings will be filed on or before Friday, May 1, 2020.
There have not been any material business developments since the Company’s financial statements and MD&A for the year ended November 30, 2019 other than as disclosed in this press release.
The Company’s management and other insiders are subject to a trading black-out that reflects the principles in section 9 of National Policy 11-207 Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions.
ON BEHALF OF PAC ROOTS CANNABIS CORP.
(signed) “Patrick Elliott”
Chief Executive Officer
For further information, please contact:
Pac Roots Cannabis Corp.
Not for distribution to United States wire services or dissemination in the United States. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward looking statements. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors.
Statements about the Target’s future facility expansion plans or Cannabis Act license application are all forward-looking information.
Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Factors that could cause the actual results to differ materially from those in forward-looking statements include failure to obtain regulatory approval, the continued availability of capital and financing, and general economic, market or business conditions, including the effects of COVID-19. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, there can be no assurance that the statements will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Readers should not place undue reliance on the Company’s forward-looking statements.
Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).